Pasithea Therapeutics KTTA Q2 2025 earnings

FAQ

When did Pasithea Therapeutics report Q2 2025 earnings?

Pasithea Therapeutics (KTTA) reported Q2 2025 earnings on August 14, 2025 before market open.

What were Pasithea Therapeutics's Q2 2025 revenue and EPS?

Pasithea Therapeutics reported eps of $-0.66 for Q2 2025.

How did Pasithea Therapeutics's Q2 2025 results compare year-over-year?

Compared to the same quarter a year prior, eps grew 82.2% from $-3.71.

Where can I find Pasithea Therapeutics's Q2 2025 SEC filings?

You can read the 10-Q periodic report (0001213900-25-076557) directly on SEC EDGAR. The filing index links above go to sec.gov.